Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
INBX:NASDAQ
Inhibrx Biosciences Inc
$131.45
+1.85%
(+2.39) 1D
$131.45
0.00% (0.00)
After hours
Closed: Apr 27, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INBX...
Open
$129.15
High
$133.00
Low
$125.42
Mkt. cap
1.92B
Avg. vol.
253.81K
Volume
62.00
52-wk high
$133.00
52-wk low
$10.84
EPS
-$9.04
Shares outstanding
14.61M
No. of employees
110
News stories
From sources across the web
About Inhibrx Biosciences Inc
CEO-
Employees110
Founded2024
HeadquartersLa Jolla, California, United States
SectorBiotechnology
Last report
Mar 19, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-2.11/ (-2.08 est.)USD
-1.44%miss
Revenue / Estimate
0.00/ (0.00 est.)USD
0.00%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
1.30M
-
-
Cost of goods sold
36.88M
22.27M
28.54M
25.35M
Cost of revenue
36.88M
22.27M
28.54M
25.35M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.02M
6.42M
5.28M
5.57M
Operating expense
6.02M
6.42M
5.28M
5.57M
Total operating expenses
42.90M
28.69M
33.81M
30.92M
Operating income
-42.90M
-27.39M
-33.81M
-30.92M
Other non operating income
-50.00K
-246.00K
-46.00K
-39.00K
EBT including unusual items
-43.31M
-28.65M
-35.26M
-32.83M
EBT excluding unusual items
-43.31M
-28.65M
-35.26M
-32.83M
Income tax expense
-
2.00K
-
-
Effective tax rate
-
-0.01%
-
-
Other operating expenses
-
-
-
-
Net income
-43.31M
-28.65M
-35.26M
-32.83M
Net profit margin
-
-2,204.15%
-
-
Earnings per share
-2.80
-1.85
-2.28
-2.11
Interest and investment income
2.33M
2.12M
1.78M
1.31M
Interest expense
-2.69M
-3.14M
-3.18M
-3.18M
Net interest expenses
-360.00K
-1.02M
-1.40M
-1.87M
Depreciation and amortization charges
-
-
-
-
EBITDA
-42.23M
-26.73M
-33.23M
-30.36M
Gain or loss from assets sale
-
-
3.00K
9.00K
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more